Analyzing the structure of your interest aptamers and their binding complex is beneficial for the exploration of potential therapeutic aptamers and targets. Creative Biolabs is a leading biotechnology company that has the expertise and ability to provide aptamer structure analysis services for customers worldwide.
Contact our team to get an inquiry now!Aptamers, or "chemical antibodies," are single-stranded oligonucleotides that fold into intricate three-dimensional shapes to bind targets with high specificity. Unlike traditional linear sequences, their function is dictated by spatial conformations such as G-quadruplexes, pseudoknots, and hairpins. Modern research, including 2025 structural surveys, reveals that nearly 25% of DNA aptamers possess "hidden" quadruplex motifs that govern binding efficacy. Aptamer structure analysis is the process of deciphering these 3D blueprints and the thermodynamics of "induced-fit" mechanisms. Understanding these interactions is essential for rational design, allowing for precise truncation and chemical modification to maximize biostability and affinity.
Fig.1 Schematic diagram of aptamer conformational recognition of targets to form an aptamer-target complex.1,3
We provide a comprehensive analytical suite designed to map the structural landscape of your aptamers at every level, from initial secondary topology to high-resolution atomic coordinates of the aptamer-target complex.
Our Specialized Services include:
We utilize chemical probing (SHAPE/DMS) and enzymatic digestion to establish a foundational map of paired and unpaired regions. This ensures that the computational models for your leads are grounded in empirical biochemical data.
Our high-field NMR spectroscopy is the gold standard for studying aptamers in their native solution state. We perform imino proton fingerprinting to confirm base-pairing and utilize NMR titrations to visualize exactly how your aptamer shifts conformation upon binding its target.
For projects requiring atomic-level precision, we crystallize aptamer-target complexes. This allows us to identify the specific hydrogen bonds and van der Waals forces driving the interaction, providing the ultimate "molecular fingerprint" for IP protection.
We leverage Cryo-Electron Microscopy, enhanced by RNA Origami scaffolds, to resolve the structures of aptamers bound to large or difficult targets, such as membrane proteins and viral particles.
Using the latest databases and AI tools, we provide predictive modeling and molecular dynamics simulations to prioritize sequences for synthesis and experimental validation.
We specifically screen G-rich sequences for quadruplex propensity, evaluating their stability in various ionic environments (K+ vs. Na+) to ensure predictable performance in physiological settings.
Technical Consultation: We discuss your target type, known sequence data, and specific project goals to select the optimal analytical approach.
Material Provision: Clients provide the aptamer sequence or synthesized material and the purified target molecule (protein, small molecule, or cell fragment).
Sequence Verification & 2D Probing: We begin with SHAPE or DMS probing to establish the secondary structure constraints.
Experimental Data Acquisition: Depending on the chosen path, we perform NMR, X-ray diffraction, or Cryo-EM imaging.
Thermodynamic Correlation: We integrate structural data with ITC (Isothermal Titration Calorimetry) to map the energetic landscape of the binding event.
Final Delivery: You receive a comprehensive structural report, including high-resolution 3D models (PDB format), interaction maps, and optimization recommendations.
Fig.2 Experimental validation of G4s formation.2,3
In this comprehensive 2025 study, researchers analyzed over 1,400 aptamer sequences to investigate their propensity for forming G-quadruplex (G4) structures. The research revealed that nearly 25% of DNA aptamers and 16% of RNA aptamers are predicted to form stable G-quadruplex folds, yet the word "quadruplex" appeared in only 17% of the original reporting articles. By experimentally testing 30 candidate sequences using circular dichroism and ThT fluorescence, the team confirmed G4 formation in all sequences with a G4Hunter score above 1.31. These findings highlight a significant "structural blind spot" in aptamer development, demonstrating that G4 motifs often serve as a universal recognition core that remains undetected by standard sequence analysis. Leveraging these insights, it is possible to identify and characterize these hidden structural modules, ensuring superior binding specificity and stability for their leads.
A: Yes, we utilize a combination of NMR imino proton shifts and X-ray crystallography to map the binding pockets of small-molecule aptamers, including those with sub-nanomolar affinities.
A: Many G-rich sequences spontaneously adopt quadruplex folds during the SELEX process. Identifying these is crucial because they often dictate the stability and specificity of the aptamer in different ionic environments.
A: Our team is highly experienced in analyzing modified oligonucleotides. We adjust our NMR and modeling parameters to account for the unique geometry and electronic properties of 2'-modified or backbone-altered bases.
A: We utilize Cryo-EM in conjunction with nanodisc technology or detergent micelles to resolve structures of aptamers interacting with membrane-embedded targets in a near-native environment.
A: By identifying the "minimal binding domain," we can often truncate the aptamer sequence by 30-50%. Shorter sequences are significantly cheaper to synthesize at a commercial scale.
A: This is a common challenge that we address using dynamic NMR and SAXS (Small-Angle X-ray Scattering) to characterize the ensemble of states and identify conditions that favor the active conformation.
A: In such cases, we pivot to solution-state NMR or Cryo-EM. Our multi-tiered approach ensures that we can still provide high-quality structural insights even when traditional methods face hurdles.
Creative Biolabs' expert structural biologists are dedicated to transforming your aptamer sequences into high-performance molecular tools. Our comprehensive biophysical insights ensure that your leads are optimized for maximum efficacy and stability. Contact us today to discuss your project and receive a tailored structural analysis plan.
| Cat# | Product Type | Product Name | Specie Reactivity | Applications | Inquiry |
|---|---|---|---|---|---|
| CTS-006 | Serum | Human Complement Serum (Pooled) | Human | Complement fixation assays; Haemolysis Assays | INQUIRY |
| CTS-001 | Serum | Guinea Pig Complement Serum | Guinea pig | Complement fixation assays; Haemolysis Assays | INQUIRY |
| CTR-001 | Antibody | Hemolysin (Rabbit Anti-Sheep Cell Hemolysin) | Sheep | Complement fixation assays; Haemolysis Assays | INQUIRY |
| CTP-461 | Protein | Native Human Complement C1q Protein | Human | ELISA; Functional Assays | INQUIRY |
| CTP-463 | Protein | Native Mouse Complement C1q Protein | Mouse | ELISA; Functional Assays | INQUIRY |
| CTMM-0322-JL15 | Antibody | Mouse Anti-Human C1q Monoclonal Antibody (TJL-03) [HRP] | Human | WB; IHC; ELISA | INQUIRY |
| CTP-051 | Protein | Native Human Complement C3b Protein | Human | ELISA; Functional Assays | INQUIRY |
| CTP-456 | Protein | Native Cynomolgus Monkey Complement C3b Protein | Cynomolgus Monkey | ELISA; Functional Assays | INQUIRY |
| CTApt-113 | Aptamer | Anti-Thrombin Aptamer | Anticoagulant Studies; Structural Complexes; Coagulation Monitoring | INQUIRY | |
| CTApt-217 | Aptamer | Anti-Interleukin 6 (IL-6) Aptamer | ELISA-Like Detection; Inflammatory Disease Screening | INQUIRY | |
| CTApt-615 | Aptamer | Anti-EGFR Aptamer | Targeted Delivery; Cell Internalization; Molecular Imaging | INQUIRY |
References
A: Common techniques for aptamer structure analysis include nuclear magnetic resonance (NMR) spectroscopy, X-ray crystallography, cryo-electron microscopy (cryo-EM), and computational modeling.
A: Computational modeling techniques, such as molecular docking and molecular dynamics simulations, are used to predict and refine the structures of aptamer-target complexes based on experimental data or to generate models in the absence of experimental structures.
A: By understanding the structure-function relationships of aptamers, aptamer structure analysis can guide the rational design and optimization of aptamers with improved binding affinity, specificity, and stability. Aptamer structure analysis contributes to the development of aptamer-based therapeutics for diseases, such as cancer and viral infections, as well as the design of aptamer-based biosensors for diagnostic purposes and targeted drug delivery systems.